ISHITSUKA KENJI

J-GLOBAL         Last updated: Nov 12, 2015 at 11:12
 
Avatar
Name
ISHITSUKA KENJI
Degree
Doctor(Medicine)(Kagoshima University)

Research Areas

 
 

Academic & Professional Experience

 
 
   
 
Fukuoka University University Hospital, Fukuoka University Hospital
 
2002
 - 
2003
:Instructor
 
2003
 - 
2006
:Research fellow, Dana-Farber Cancer Institute, Boston, MA
 
2006
   
 
-:Assistant professor
 

Education

 
 
 - 
1988
Faculty of Medicine, Kagoshima University
 

Misc

 
Nakano D, Ishitsuka K, Kamikawa M, Matsuda M, Tsuchihashi R, Okawa M, Okabe H, Tamura K, Kinjo J.
J Nat Med.   67(4) 894-903   2013
Nakano D, Ishitsuka K, Katsuya H, Kunami N, Nogami R, Yoshimura Y, Matsuda M, Kamikawa M, Tsuchihashi R, Okawa M, Ikeda T, Nohara T, Tamura K, Kinjo J.
J Nat Med.   67(2) 415-420   2013
Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (II): apoptosis of antiproliferactive principle (24,25-dihydrowithanolide D) against ATL cell lines and structure-activity relationships wi...
Ishitsuka K, Uchino J, Kato J, Ikuta M, Watanabe K, Matsunaga A, Tamura K.
Int J Hematol.   95(6) 731-732   2012
Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, Saburi Y, Miyamoto T, Takemoto S, Suzushima H, Tsukasaki K, Nosaka K, Fujiwara H, Ishitsuka K, Inagaki H, Ogura M, Akinaga S, Tomonaga M, Tobinai K, Ueda R.
J Clin Oncol.   30(8) 837-842   2012
Katsuya H, Yamanaka T, Ishitsuka K, Utsunomiya A, Sasaki H, Hanada S, Eto T, Moriuchi Y, Saburi Y, Miyahara M, Sueoka E, Uike N, Yoshida S, Yamashita K, Tsukasaki K, Suzushima H, Ohno Y, Matsuoka H, Jo T, Suzumiya J, Tamura K.
J Clin Oncol.   30(14) 1635-1640   2012

Books etc

 
Clinical Oncology
2008   ISBN:978-4-8306-2222-9

Conference Activities & Talks

 
A nationwide survey of adult T-cell leukemia/lymphoma newly diagnosed over the last decade in Japan
The 5th annual T-cell Lymphoma Forum   2013   
Safety and Pharmacokinetic Evaluation of Palonosetron 0.75mg iv Repeated Dose In Patients Receiving High or Moderate Emetic Risk Chemotherapy.
ESMO2012   2012   
Targeting Bcl-2 family proteins for the treatment of adult T-cell leukemia/lymphoma.
2010   
4th Symposium of ATL
2010   
A promising therapeutic implication of a novel Bcl-2 family inhibitor ABT-737 for adult T-cell leukemia/lymphoma.
50th Annual meeting of American Association of Hematology   2008   

Works

 
Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1): a potential therapeutic modality implication against natural killer/T cell malignancy.
Sep 2006 - Dec 2007

Research Grants & Projects

 
Study on Therapeutic Potential of Arsenic Trioxide
Project Year: 1997   
Translational reserach of novel agents for cancer chemotherapy
Novel therapy for adult T-cell leukemia/lymphoma
Translational research of novel agents for cancer therapy.